Research Services
INNOVHEM offers a platform of unique biological assays to meet the needs of pharma and biotech companies, in terms of validation of clinical claims, with expert innovations.
OUR SERVICES

Our proprietary biomarkers support treatment development and validation and patient monitoring for sickle cell disease and all other indications involving red blood cells.

Thanks to our scientific and clinical expertise, INNOVHEM’s R&D team can develop custom biomarkers and assays for specific needs in red blood cell pathologies.
Blood Sample

SINGLE CELL HbF QUANTIFICATION

Intravascular Hemolysis

Sickling assay

Key advantages
CLINICAL AND SCIENTIFIC EXPERTISE
INCREASE THE QUALITY OF EVIDENCE PRESENTED